numerous Cattlyst Generic Name: laidlomycin propionate potassium Dosage Form: FOR ANIMAL USE ONLY Cattlyst 50G Laidlomycin propionate potassium Type A Medicated Article For improved feed efficiency and increased rate of weight gain in cattle fed in confinement for slaughter. Active Drug Ingredient Laidlomycin propionate potassium, 50 grams per pound, in a carrier suitable for incorporation in feed. Weight Gain and Feed Efficiency For increased rate of weight gain and improved feed efficiency when incorporated into complete cattle feed at 5 g/ton to provide not less than 30 mg and not more than 75 mg per head per day. Feed Efficiency For improved feed efficiency when incorporated into complete cattle feed at 5 to 10 g/ton to provide not less than 30 mg and not more than 150 mg per head per day. Mixing And Feeding Instructions Read all directions carefully before mixing and feeding. DO NOT FEED UNDILUTED Type B Medicated Feed Thoroughly mix the following amounts of Cattlyst 50G to make one ton of Type B Medicated Feed to provide the concentrations shown in TABLE 1. With low use levels of Cattlyst 50G (e.g. two lb/ton or less), the use of an intermediate blending step should be performed to ensure adequate mixing. Liquid feeds made with Cattlyst 50G shall have a dry matter content in the range of 62%-75%, pH in the range of 6.0-8.0 and drug level of 100-2000 g/ton. Its label shall carry daily and prior to use recirculating/agitation directions and an expiration of 21 days from date of manufacture. The Type C feed made with this Type B liquid feed shall be fed within seven days from date of manufacture. TABLE 1 - Type B Medicated Feed Pounds of Cattlyst 50G per ton of supplement Laidlomycin Concentration in Type B Medicated Feed (Grams per ton) 2.0 100 4.0 200 20.0 1000 40.0 2000 Type C Medicated Feed Thoroughly mix the following amounts of Cattlyst 50G to make one ton of Type C Medicated Feed that provides 5-10 grams of laidlomycin propionate potassium per ton of feed on a 90% dry matter basis (TABLE 2). An intermediate blending step should be performed to ensure adequate mixing. For example, use one part Cattlyst 50G Type A Medicated Article with nine parts of feed ingredients to prepare an intermediate blend before preparing a Type C Medicated Feed. Feed continuously in the range of 5-10 grams per ton to growing and finishing beef cattle. TABLE 2 - Type C Medicated Feed Pounds of Cattlyst 50G per ton of complete feed Pounds of a 1,000 g/ton Type B Medicated Feed per ton of complete feed Laidlomycin Concentration in complete Type C feed 90% dry matter basis (grams per ton) 0.1 10 5 0.15 15 7.5 0.20 20 10 Caution Do not allow horses or other equines access to feeds containing laidlomycin propionate potassium (Cattlyst 50G). The safety of laidlomycin propionate potassium (Cattlyst 50G) in unapproved species has not been established. Not for use in animals intended for breeding. Warning When mixing and handling Cattlyst 50G use appropriate protective clothing, eye, face, and respiratory protection. If accidental eye or skin contact occurs, rinse immediately with water. Operators should wash thoroughly with soap and water after handling Cattlyst 50G. Keep container closed between uses. Store below 25 C (77 F), excursions permitted to 37 C (99 F). NADA 141-025, Approved by FDA Alpharma Inc. Bridgewater, New Jersey 08807 Net wt 50 LB (22.68 kg) Trademarks registered by Alpharma Inc. 780301 0905 PRINCIPAL DISPLAY PANEL Cattlyst 50G ALPHARMA Laidlomycin propionate potassium Type A Medicated Article See mixing directions, claims, cautions and warnings on back Net wt 50 LB (22.68 kg) Cattlyst 50 G laidlomycin propionate potassium powder Product Information Product Type OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG Item Code (Source) NDC:46573-000 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Laidlomycin Propionate Potassium (Laidlomycin) Laidlomycin 50 g in 0.45 kg Product Characteristics Color WHITE (white to off white) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:46573-000-00 22.68 kg in 1 BAG Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NADA NADA141025 01/01/2009 Labeler - Alpharma Inc. Animal Health (070954094) Revised: 06/2009 Alpharma Inc. Animal Health Print this page FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More no use
learn Cattlyst undercover agent
EmoticonEmoticon